Applications of Digital and Computational Pathology and Artificial Intelligence in Genitourinary Pathology Diagnostics – Dr. Mahul Amin
Multiparametric MRI in Prostate Cancer Diagnosis and Management: Role of Pathologist – Dr. Cristina Magi-Galluzzi (9:15 AM-10:00 AM, 45 minutes)
Contemporary Update on Prostate Cancer Grading – Dr. Ming Zhou (10:00 AM-10:45 AM, 45 Minutes)
Divergent Differentiations and Variant Histologies of Bladder Cancer – Dr. Gladell Paner (11:00 AM – 11:45 AM, 45 Minutes)
How New Developments Impact Diagnosis in Existing Renal Neoplasms – Dr. Sean Williamson (11:45 AM – 12:30 PM, 45 minutes )
Germ Cell Tumors of the Testis: Diagnoses that You Do Not Want to Miss – Dr. Andres Acosta (1:30 PM- 2:15 pm, 45 Minutes)
Penile Cancer: A pathologist’s perspective for current trends in diagnosis, staging, and treatment – Dr. Jasreman Dhillon (2:15 PM- 3:00 PM, 45 Minutes)
Case-based discussions (15 Minutes + 5 Minutes for Q&A):
Communicating Pathology Results for Personalized Medicine: How Are the Surgical Members of the Society of Urologic Oncology Using Pathology Reports to Guide the Treatment of Prostate Cancer Patients? - Dr. Murali Varma (8:30 AM- 9:15 AM, 45 Minutes)
Large Gland Lesions of the Prostate: Current Concepts, Controversies, and Future directions – Dr. Rajal Shah (9:15 AM- 10:00 AM, 45 minutes)
Pathologic sub-staging of bladder cancer – updates, controversies, and guidelines – Dr. Ankur Sangoi (10:00 AM- 10:45 AM, 45 minutes)
Pink Cell Tumors of the Kidney: Making Sense – Dr. Rohit Mehra (11:00 AM-11:45 AM, 45 minutes)
Best practice recommendation for immunohistochemical markers in renal cell tumors – Dr. Mahmut Akgul (11:45 AM- 12:30 PM, 45 minutes)
Quiz- Dr Akhil Kapoor (1.30 PM to 1.35 PM, 5 minutes)
Non-muscle invasive bladder cancer: Management principles and recent advances - Dr. Ravimohan (1.35 PM to 1.50 PM, 15 minutes)
Debate: Bladder Preservation Strategies in Bladder Cancer - Combined modality treatment is preferred over Radical cystectomy in locally advanced bladder cancer -1.50 PM to 2.10 PM, 20 minutes
Dr. Manas Pradhan : 8 minutes
Dr Indraneel (Radiation oncologist) : 8 minutes
Expert comment : Dr. Surendra N. Senapati
4. Panel discussion : 2.10 PM - 2.45 PM, 35 minutes
Neoadjuvant and adjuvant strategies in bladder cancer.
Moderator : Dr. Vineet Talwar
Metastatic Urothelial Carcinoma: New Horizons with emphasis on Antibody Drug Conjugates: Keynote speech: Dr. Ajjai Alva (2.45 PM - 3.15 PM, 30 minutes)
Clinical management of subtype histologies of bladder cancer (15 min): 3.15 PM - 3.30 PM Dr Anita Ramesh
Renal cell carcinoma: (1 hour 45 minutes)
Quiz : Dr. Srigopal Mohanty (3.45 PM - 3.50 PM, 5 minutes)
Small renal masses: approach and Current guidelines: Dr. Ravindra Sabnis – (3.50 PM - 4.05 PM, 15 minutes)
Debate RCC: Adjuvant immunotherapy is the current standard of care in newly diagnosed RCC – (4.05 PM - 4.25 PM, 20 minutes)
For : Dr. Atul Batra
Against : Dr. Amol Akhade
Expert comments : Dr. Dipti R. Samanta
Combining systemic therapy with local therapy (SBRT) in MRCC - Dr Srinivas Chilikuri (4.25 PM - 4.40 PM, 15 minutes)
Panel discussion : Metastatic clear cell carcinoma: Case based discussion – (4.40 PM - 5.15 PM, 35 minutes)
Moderator : Dr. Atul Sharma
Sarcomatoid Kidney : important diagnostic and therapeutic considerations –Keynote: Dr. Philippe Speiss (5.15 PM - 5.45 PM, 30 minutes)
Prostate Cancer Screening: Controversies and Consensus - The latest guidelines and evidence. Dr. Chirag Desai (9:00 AM – 9:15 AM, 15 minutes)
3. Debate: Use of next generation imaging is preferred over conventional imaging in management of advanced prostate cancer: 9:15 AM – 9:35 AM, 20 minutes
For: Dr. Kanhaiya Agarwal
Against: Dr. Manas Kar
Expert comment: Dr. Chirag Desai
4. Oligometastatic prostate cancer: Current understanding and consensus on multi-modality management-Dr. Sandy Srinivas (9:35 AM – 10:05 AM, 30 minutes) (Keynote address)
5. Panel discussion: Locally advanced prostate cancer 9:50 AM - 10:20 AM, 30 minutes
Moderator: Dr. Vedang Murthy
Metastatic hormone sensitive prostate cancer the right sequence-Dr Amit Joshi (10:20 AM-10:40 AM, 20 minutes)
Panel discussion: Castrate resistant prostate cancer (10.40AM- 11.10 AM, 30 minutes)
Moderator: Dr. T. Raja
Miscellaneous: (2 hours)
1. Role of HPV in the management of penile cancer: Where do we stand? Dr. Philippe Speiss- (11.25 AM to 11.55 AM, 30 minutes)
2. Genitourinary malignancies: Making sense of Indian data with emphasis on conducting collaborative research- Dr. Atul Batra (11.55 AM to 12.10 PM, 15 minutes)
3. Neuroendocrine carcinoma in urogenital tract: Multimodality management in case-based discussions-12.10 PM to 12.40 PM, 30 minutes
Moderator: Dr. Senthil Rajappa
International Congress on Uro Oncology & Pathology an international conference that will take place in the temple city of Bhubaneswar, Odisha, India, from 10th to 12th January, 2025.
gupsindiaconclave@iaoncology.org
Copyright © 2024. All Rights Reserved